EL-22 is a novel myostatin asset for the potential treatment of obesity in combination with existing GLP-1 medicines The Investigational New Drug application is planned for submission to the U.S. Food ...
Harry Aikines-Aryeetey has myostatin deficiency Getty Images; design: Kelsea Petersen “A blessing and a curse” is how Harry Aikines-Aryeetey describes the genetic quirk that means his body carries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results